Filter Results:
(6,986)
Show Results For
- All HBS Web
(6,986)
- People (27)
- News (2,576)
- Research (3,458)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,234)
Show Results For
- All HBS Web
(6,986)
- People (27)
- News (2,576)
- Research (3,458)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,234)
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details
Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 21 Aug 2017
- Lessons from the Classroom
Companies Love Big Data But Lack the Strategy To Use It Effectively
Administration at Harvard Business School. “Used well, it changes the basis of competition in industry after industry.” The problem is that, in many cases, big data is not used well. Companies are better at collecting data–about their... View Details
Keywords: by Dina Gerdeman
- 01 Dec 2007
- News
Where Are the Innovators in Health Care?
billion of the excessive costs of U.S. health care while all too many quality measures have worsened. Patients learn — sometimes the hard way — to bring along an assertive, intelligent loved one to protect... View Details
- 19 Aug 2016
- News
Using Technology to Help Reclaim Lives from Addiction
“Lionrock is my revenge against addiction,” says Peter Loeb (MBA 1991), cofounder and chief executive of Lionrock Recovery, the largest online addiction recovery program in the US and Canada. “This venture is part of my healing.” A... View Details
- 27 Apr 2021
- Research & Ideas
New Research: Surviving Bankruptcy, Useful Economics, and Retirement
use of remote patient monitoring services grows—driven by health care limitations imposed by the COVID-19 pandemic—clinicians, payers, and patients face important questions... View Details
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- Article
Consumer-Driven Health Care: Freeing Providers to Innovate
Herzlinger, Regina E. "Consumer-Driven Health Care: Freeing Providers to Innovate." hfm (Healthcare Financial Management) 58, no. 3 (March 2004): 66–68.
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
- 19 Dec 2023
- Research & Ideas
$15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy
comparison group. Top causes: education and health care Between 2020 and 2022, nonprofits in the youth, philanthropy, and housing sectors represented a larger share of grantees compared with the size of... View Details
- 24 Mar 2020
- Research & Ideas
These Coronavirus Heroes Show Us How Crisis Leadership Works
their companies. If ever there was a time for leaders to be authentic, this is it. They need to be humble, open, and realistic about the health care and logistical challenges they are facing while View Details
- 29 Aug 2016
- News
Health Insurers’ Pullback Threatens to Create Monopolies
- 18 Oct 2016
- News
Why Business Should Invest in Community Health
- April 2013
- Article
Rx: Human Nature: How Behavioral Economics Is Promoting Better Health Around the World
By: Nava Ashraf
Why doesn't a woman who continues to have unwanted pregnancies avail herself of the free contraception at a nearby clinic? What keeps people from using free chlorine tablets to purify their drinking water? Behavioral economics has shown us that we don't always act in... View Details
Ashraf, Nava. "Rx: Human Nature: How Behavioral Economics Is Promoting Better Health Around the World." Harvard Business Review 91, no. 4 (April 2013): 119–125.
- 01 May 2008
- News
Interview: Does Our Health System Deliver Value?
- 01 Jan 2008
- News
Value-based Health Care: The MD Anderson Experience
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- Web
Health Business Fulltext Elite | Baker Library
Health Business Fulltext Elite Journal articles on all non-clinical aspects of health care management. Read More Includes aspects of health View Details
- Article
Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization
By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp
In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details
Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States
Chen, Lucy, Richard G. Frank, and Haiden A. Huskamp. "Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization." Inquiry 57 (2020).
- March 2022 (Revised July 2022)
- Case
Nexleaf Analytics: Saving the World Using the Internet of Things
By: Frank Nagle
In 2019, a decade after co-founding Nexleaf Analytics, CEO Nithya Ramanathan faced an important decision that would impact the ability of the small, but growing, not-for-profit organization to thrive for another decade. Their sensor technologies and big data analytics... View Details
Keywords: Corporate Strategy; Collaborative Innovation and Invention; Technological Innovation; Nonprofit Organizations; Competitive Strategy; Patents; Expansion; Information Technology; Health Industry; Information Industry; Medical Devices and Supplies Industry; Technology Industry
Nagle, Frank. "Nexleaf Analytics: Saving the World Using the Internet of Things." Harvard Business School Case 722-414, March 2022. (Revised July 2022.)